Catheter-based arterial sympathectomy: hypertension and beyond.
Prince EA, Murphy TP, Hampson CO.
J Vasc Interv Radiol. 2012 Sep;23(9):1125-34; quiz 1134. doi: 10.1016/j.jvir.2012.06.018.
Synchronous Laser Ablation and Transluminal Foam Sclerotherapy through a Single Ablation Catheter.
Georgakarakos E, Doukas D, Bontinis V, Georgiadis GS.
Eur J Vasc Endovasc Surg. 2026 Mar;71(3):516-517. doi: 10.1016/j.ejvs.2025.12.004. Epub 2025 Dec 4.
A pilot study on coronary microvascular dysfunction in obstructive hypertrophic cardiomyopathy: impact of percutaneous transluminal septal myocardial ablation.
Terauchi T, Hiraya D, Usami K, Yaguchi T, Watabe H, Hoshi T, Ishizu T.
Cardiovasc Interv Ther. 2025 Oct;40(4):973-981. doi: 10.1007/s12928-025-01154-1. Epub 2025 Jun 27.
Endoscopic ultrasonography-guided ablation therapy.
Trevino JM, Varadarajulu S.
J Hepatobiliary Pancreat Sci. 2011 May;18(3):304-10. doi: 10.1007/s00534-010-0352-7.
Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H, Faber L, Gleichmann U.
Thorac Cardiovasc Surg. 1999 Apr;47(2):94-100. doi: 10.1055/s-2007-1013118.
A randomized controlled trial to evaluate the safety and efficacy of transluminal injection of foam sclerotherapy compared with ultrasound-guided foam sclerotherapy during endovenous catheter ablation in patients with varicose veins.
Watanabe S, Okamura A, Iwamoto M, Nagai H, Sumiyoshi A, Tanaka K, Suzuki S, Tanaka H, Iwakura K, Fujii K.
J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):75-81.e1. doi: 10.1016/j.jvsv.2021.06.017. Epub 2021 Jul 10.
Is There a Role for Alcohol Septal Ablation in Young Patients with Medically Refractory Hypertrophic Obstructive Cardiomyopathy?
Sivakumar K, Jain G.
Pediatr Cardiol. 2024 Mar;45(3):648-659. doi: 10.1007/s00246-023-03145-6. Epub 2023 Mar 30.
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S.
J Am Coll Cardiol. 1998 Feb;31(2):252-8. doi: 10.1016/s0735-1097(97)00508-1.
Transluminal radiofrequency tissue ablation with use of metallic stents.
Goldberg SN, Ryan TP, Hahn PF, Schima W, Dawson SL, Lawes KR, Mueller PR, Gazelle GS.
J Vasc Interv Radiol. 1997 Sep-Oct;8(5):835-43. doi: 10.1016/s1051-0443(97)70669-9.
New technologies for the treatment of obstructive arterial disease.
Fischell TA, Stadius ML.
Cathet Cardiovasc Diagn. 1991 Mar;22(3):205-33. doi: 10.1002/ccd.1810220311.
